These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38512372)

  • 1. Association of serum sodium levels with fractures and mortality in patients undergoing maintenance hemodialysis.
    Soeda K; Komaba H; Nakagawa Y; Kawabata C; Wada T; Takahashi H; Takahashi Y; Hyodo T; Hida M; Suga T; Kakuta T; Fukagawa M
    J Nephrol; 2024 Jun; 37(5):1339-1349. PubMed ID: 38512372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis.
    Nagata Y; Inaba M; Imanishi Y; Okazaki H; Yamada S; Mori K; Shoji S; Koyama H; Okuno S
    Osteoporos Int; 2015 Mar; 26(3):1053-61. PubMed ID: 25403902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients.
    Cao Y; Liu X; Xu H
    Clin Lab; 2012; 58(7-8):845-50. PubMed ID: 22997989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry.
    Glendenning P; Kent GN; Adler BD; Matz L; Watson I; O'Driscoll GJ; Hurley DM
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):347-55. PubMed ID: 10435061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients.
    Ishimura E; Okuno S; Ichii M; Norimine K; Yamakawa T; Shoji S; Nishizawa Y; Inaba M
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4315-20. PubMed ID: 25093620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.
    Atteritano M; Di Mauro E; Canale V; Bruzzese AM; Ricciardi CA; Cernaro V; Lacquaniti A; Buemi M; Santoro D
    Osteoporos Int; 2017 Feb; 28(2):577-584. PubMed ID: 27682249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Tamaki J; Iki M; Kadowaki E; Sato Y; Chiba Y; Akiba T; Matsumoto T; Nishino H; Kagamimori S; Kagawa Y; Yoneshima H;
    Osteoporos Int; 2013 Mar; 24(3):887-97. PubMed ID: 22885773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.
    Malluche HH; Davenport DL; Cantor T; Monier-Faugere MC
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1254-62. PubMed ID: 24948144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Fracture Risk From Early-Stage Bone Markers in Patients With Osteoporosis Treated With Once-Yearly Administered Zoledronic Acid.
    Kasai H; Mori Y; Ose A; Shiraki M; Tanigawara Y
    J Clin Pharmacol; 2021 May; 61(5):606-613. PubMed ID: 33135182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density.
    Cohen A; Recker RR; Lappe J; Dempster DW; Cremers S; McMahon DJ; Stein EM; Fleischer J; Rosen CJ; Rogers H; Staron RB; Lemaster J; Shane E
    Osteoporos Int; 2012 Jan; 23(1):171-82. PubMed ID: 21365462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of COLIA1 polymorphism and bone turnover markers to identify postmenopausal women with prevalent vertebral fractures.
    Mezquita-Raya P; Muñoz-Torres M; de Dios Luna J; Lopez-Rodriguez F; Quesada JM; Luque-Recio F; Escobar-Jiménez F
    Osteoporos Int; 2002; 13(6):506-12. PubMed ID: 12107666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
    Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyponatremia and Fractures: Findings From the MrOS Study.
    Jamal SA; Arampatzis S; Harrison SL; Bucur RC; Ensrud K; Orwoll ES; Bauer DC
    J Bone Miner Res; 2015 Jun; 30(6):970-5. PubMed ID: 25294595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic of bone turnover markers after osteoporotic vertebral compression fractures in postmenopausal female.
    Pan C; Liu X; Li T; Wang G; Sun J
    J Orthop Surg Res; 2018 Dec; 13(1):314. PubMed ID: 30526635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineral bone disorder and osteoporosis in hemodialysis patients.
    Slouma M; Sahli H; Bahlous A; Laadhar L; Smaoui W; Rekik S; Gharsallah I; Sallami M; Moussa FB; Elleuch M; Cheour E
    Adv Rheumatol; 2020 Feb; 60(1):15. PubMed ID: 32102689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone turnover in passive smoking female rat: relationships to change in bone mineral density.
    Gao SG; Li KH; Xu M; Jiang W; Shen H; Luo W; Xu WS; Tian J; Lei GH
    BMC Musculoskelet Disord; 2011 Jun; 12():131. PubMed ID: 21663694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sRANKL/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients.
    Doumouchtsis KK; Kostakis AI; Doumouchtsis SK; Tziamalis MP; Tsigris C; Kostaki MA; Perrea DN
    J Endocrinol Invest; 2007 Oct; 30(9):762-6. PubMed ID: 17993768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Turnover Marker Profiling and Fracture Risk in Older Women: Fracture Risk from Age 75 to 90.
    Ivaska KK; McGuigan FE; Malmgren L; Gerdhem P; Johansson H; Kanis JA; Akesson KE
    Calcif Tissue Int; 2022 Sep; 111(3):288-299. PubMed ID: 35750934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.
    Costa AG; Walker MD; Zhang CA; Cremers S; Dworakowski E; McMahon DJ; Liu G; Bilezikian JP
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4736-43. PubMed ID: 24037879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Bone Mineral Density, Bone Turnover Markers, and Vertebral Fractures with All-Cause Mortality in Type 2 Diabetes Mellitus.
    Miyake H; Kanazawa I; Sugimoto T
    Calcif Tissue Int; 2018 Jan; 102(1):1-13. PubMed ID: 28965188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.